The Moment to Alter Chronic
Kidney Disease is Now.
The Moment to Alter Chronic Kidney Disease is Now.
Improving Lives with Early Detection and Management of Kidney Disease
Imagine a world where a simple test extends lives, where technology offers not just data, but hope, time with loved ones, and new beginnings. In partnership with Nova Biomedical, we are making this a reality. Our groundbreaking platform is a lifeline to millions globally affected by kidney disease and transforming care delivery in diverse care settings. By empowering health systems, outpatient clinics and public health leaders with critical early detection and proactive management tools, we are changing the narrative of kidney health care.
We envision a world where kidney health is proactive, accessible, and patient-centric, fundamentally improving outcomes and quality of life globally.
A New Technology Era in Kidney Care
Leading Identification and Management of Chronic Kidney Disease (CKD) with a Comprehensive Tech Platform
Our clinical-grade, CE-cleared devices, like Nova Pro Max Creatinine and Nova Biomedical Allegro, instantly provide crucial health metrics such as creatinine,
, and from just a few drops of blood, urine, and vital signs. These results are immediate and shareable in real-time with the clinical team through our state-of-the-art connectivity technology.The Carna platform, featuring the user-friendly Carna Patient App, Carna Care Team App and Carna Physician Portal, integrates effortlessly with existing healthcare systems’ EHRs. This synergy ensures a proactive, smooth and personalized healthcare journey, connecting patients and healthcare professionals like never before.
Carna Health’s Pillars of Advanced Healthcare
Our Visionary Healthcare Solutions: An Overview
Health Equity: A Right, not a Privilege
Accessible, Affordable Healthcare for All
Envision a world free from healthcare boundaries, where every individual, regardless of background, has access to quality, affordable care. Carna Health is actively creating this world. With over 850 million people worldwide affected by chronic kidney disease (CKD) – a silent killer that 90% of sufferers are unaware of – our mission is more critical than ever. We stand at the forefront of addressing this silent epidemic, which is projected to become the 5th leading cause of death globally by 2040. Join us in bridging the gap in healthcare, ensuring that no one is left behind in our pursuit of health equity.